Recombinant erythropoietin in the treatment of anemia in cancer patients

S. V. Vorobiova; Воробьева С. В.; T. Z. Cherniavskaya; Чернявская Т. З.; S. G. Pushkareva; Пушкарева С. Г.; G. P. Frolov; Фролов Г. П.; K. N. Melkova; Мелкова К. Н.

doi:10.17650/1818-8346-2007-0-3-76-80

Recombinant erythropoietin in the treatment of anemia in cancer patients

Authors: Vorobiova S.V.¹, Cherniavskaya T.Z.¹, Pushkareva S.G.², Frolov G.P.², Melkova K.N.¹
Affiliations:
1. N.N. Blokhin Cancer Research Cente
2. State Research Center –Institute of biophysics
Issue: No 3 (2007)
Pages: 76-80
Section: SEMINAR IN HEMATOLOGY
Published: 23.08.2007
URL: https://oncohematology.abvpress.ru/ongm/article/view/684
DOI: https://doi.org/10.17650/1818-8346-2007-0-3-76-80
ID: 684

Cite item

Full Text

Abstract
About the authors
References
Supplementary files
Statistics

Abstract

This article reviews the role of recombinant erythropoietin in the management of anemia in cancer patients based on literature data and our experience. We describe the problem of toxicity and report clinical recommendations and cautions for usage of drugs appertain to this pharmaceutical group.